Lexaria Bioscience Corp. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Common Shares and Warrants (Tables)

Common Shares and Warrants (Tables)

9 Months Ended

May 31, 2016

Schedule of Capital Stock, Warrants [Table Text Block]

			Weighted Average
	Number of		Exercise Price
	Warrants		$
Balance, August 31, 2014	12,954,713		0.25
Expired	(552,380	)	0.40
Issued	5,634,200		0.25
Balance, August 31, 2015	18,036,533		0.25
Expired	(12,868,286	)	0.24
Dividend from forward split	693,653		N/A
Issued	1,049,150		0.18
Balance, May 31, 2016	6,911,050		0.24

Schedule of Summary of Warrants Outstanding [Table Text Block]

# of Warrants	Weighted	Weighted
	Average	Average
	Remaining	Exercise Price
	Contractual Life	$
5,500,000	0.95 years	0.23
361,900	0.95 years	0.18
758,750	1.38 years	0.15
290,400	1.53 years	0.27
6,911,050	1.02 years	0.24

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References + Details